The in vitro interaction of trimethoprim and sulfamethoxazole on clinical isolates of Paracoccidioides brasiliensis was studied. With complete inhibition and a visual endpoint used as the criteria, three of four strains had minimal inhibitory concentrations that indicated resistance to sulfamethoxazole, and all four strains were resistant to trimethoprim. A marked synergism in inhibition was noted with the combination of these drugs against sulfa-resistant strains. A sulfamethoxazole/trimethoprim ratio of 5:1 was the most synergistic. Fifty percent inhibition, determined spectrophotometrically, of the strains could be achieved with sulfamethoxazole alone. In summary, the striking synergy observed suggests that combination chemotherapy with these drugs deserves further study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC182028 | PMC |
| http://dx.doi.org/10.1128/AAC.21.5.852 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spatial distribution patterns, hotspots of contaminants of emerging concern and driving factors in a river network of Xizang Plateau.
Environ Res
January 2025
CAS Key Laboratory of Urban Pollutant Conversion, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen, 361021, China. Electronic address:
This study encompasses the explication of systematic spatial distribution patterns and identification of hotspots of contaminants of emerging concern (CECs) across the network of rivers, including Yarlung Tsangpo River and its tributaries in Xizang Plateau. A total of 16 CECs were detected in wide range of frequencies and concentrations ranging from below limit of detection (BLD) - 163.13 ng/L across the river network, indicating widespread spatial heterogeneity.
View Article and Find Full Text PDFAntimicrobial Resistance in African Great Apes.
Antibiotics (Basel)
November 2024
Department of Biology and Animal Ecology, Research Institute for Tropical Ecology (IRET/CENAREST), Libreville BP 13354, Gabon.
Background/objectives: Antibiotic-resistant bacteria pose a significant global public health threat that demands serious attention. The proliferation of antimicrobial resistance (AMR) is primarily attributed to the overuse of antibiotics in humans, livestock, and the agro-industry. However, it is worth noting that antibiotic-resistant genes (ARGs) can be found in all ecosystems, even in environments where antibiotics have never been utilized.
View Article and Find Full Text PDFMolecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors.
BMC Chem
December 2024
Laboratory of Preservation Technology and Enzyme Inhibition Studies, Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India.
Dihydrofolate reductase (DHFR) is an enzyme that plays a crucial role in folate metabolism, which is essential for cell growth and division. DHFR has been identified as a molecular target for numerous diseases due to its significance in various biological processes. DHFR inhibitors can disrupt folate metabolism by inhibiting DHFR, leading to the inhibition of cell growth.
View Article and Find Full Text PDFProphylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate.
Ann Hematol
December 2024
Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
This retrospective study investigated the potential drug-drug interactions between trimethoprim-sulfamethoxazole (TMP-SMZ) and high-dose methotrexate (HD-MTX) in adult patients with primary central nervous system lymphoma (PCNSL). A total of 143 Chinese adult patients with PCNSL who received 498 cycles of MTX were included. Differences in the pharmacokinetics of MTX, including C, clearance (CL) and AUC with and without co-administration of TMP-SMZ were assessed.
View Article and Find Full Text PDFCo-prescription of low-dose methotrexate and trimethoprim-sulfamethoxazole and the 30-day risk of death among older adults: A cohort study.
Br J Clin Pharmacol
December 2024
ICES, Toronto, ON, Canada.
Article Synopsis
- - The study aimed to assess the death risk in older adults taking low-dose methotrexate when also prescribed TMP-SMX compared to a cephalosporin.
- - Researchers matched 1,602 adults on each antibiotic to analyze the 30-day outcomes, finding similar death rates but increased risks of hospitalization and infection with TMP-SMX.
- - The conclusion indicated no higher death risk from TMP-SMX, but it was linked to increased hospitalization rates, suggesting that the benefits of this co-prescription need careful consideration.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!